Clinical trial

A Multicentre Randomised Controlled Trial Comparing Two Strategies for the…

NCT00163722 · Bayside Health, Other · Completed

Key facts

NCT number NCT00163722
Title A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-risk Haematology Patients
Official title A Multicentre Randomised Controlled Trial Comparing the Current Standard Diagnostic Strategy for Invasive Aspergillosis to the New Diagnostic Strategy for Invasive Aspergillosis in High-Risk Haematology Patients in Order to Determine Which Strategy Results in the Lower Rates of Use of Empiric…
Lead sponsor Bayside Health, Other
Collaborators National Health and Medical Research Council, Australia
Status Completed
Phase Phase 3
Study type Interventional
Conditions Invasive Aspergillosis
Intervention type Other
Interventions Culture and histology, Aspergillus galactomannan and PCR
Enrollment 240
Start date Sep 1, 2005
Primary completion Jan 1, 2011
Completion Aug 1, 2011
First posted Sep 14, 2005
Last update posted Feb 20, 2013
Countries Australia

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies